Product Introduction:
Odivir Kit 300/400/600 mg Tablet is a fixed-dose combination of three antiretroviral agents: Lamivudine (a nucleoside reverse transcriptase inhibitor), Didanosine (a nucleoside reverse transcriptase inhibitor), and Efavirenz (a non-nucleoside reverse transcriptase inhibitor). This combination works synergistically to suppress HIV replication and improve immune system function.
Uses:
-
Treatment of HIV-1 infection in adults
-
Part of antiretroviral therapy (ART) regimens
Benefits:
-
Reduces viral load in HIV-infected individuals
-
Increases CD4 cell counts
-
Delays progression to AIDS
-
Improves quality of life and survival rates
Composition:
-
Lamivudine 300 mg
-
Didanosine 400 mg
-
Efavirenz 600 mg
Side Effects:
-
Headache
-
Nausea
-
Diarrhea
-
Rash
-
Flatulence
-
Depression
-
Insomnia
-
Dizziness
-
Drowsiness
-
Nightmares
-
Tiredness
-
Fever
-
Peripheral neuropathy
-
Dry mouth
-
Muscle damage
-
Decreased white blood cell count
-
Anemia
Safety Advice:
-
Pregnancy: Not recommended; consult your doctor.
-
Breastfeeding: Use with caution; consult your doctor.
-
Alcohol: Avoid alcohol consumption.
-
Liver: Use with caution in patients with liver disease; consult your doctor.
-
Kidney: Use with caution in patients with kidney disease; consult your doctor.
-
Driving: May cause dizziness; avoid driving or operating machinery if affected
